Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Sep 30, 2016 $2.01 $2.01 $1.97 $2.00 369 800
Sep 29, 2016 $2.08 $2.10 $1.98 $2.01 559 200
Sep 28, 2016 $2.05 $2.09 $2.02 $2.06 416 000
Sep 27, 2016 $2.13 $2.13 $2.00 $2.07 732 600
Sep 26, 2016 $2.11 $2.11 $1.95 $2.10 1 149 500
Sep 23, 2016 $2.17 $2.18 $2.08 $2.11 836 600
Sep 22, 2016 $2.25 $2.35 $2.13 $2.16 3 287 200
Sep 21, 2016 $2.14 $2.17 $2.01 $2.10 2 209 400
Sep 20, 2016 $2.38 $2.38 $2.03 $2.09 8 606 200
Sep 19, 2016 $1.70 $1.77 $1.70 $1.75 61 500
Sep 16, 2016 $1.75 $1.80 $1.68 $1.68 69 300
Sep 15, 2016 $1.73 $1.76 $1.73 $1.75 131 200
Sep 14, 2016 $1.68 $1.75 $1.68 $1.72 119 500
Sep 13, 2016 $1.76 $1.80 $1.69 $1.70 88 600
Sep 12, 2016 $1.77 $1.79 $1.72 $1.76 86 400
Sep 09, 2016 $1.83 $1.85 $1.75 $1.77 132 600
Sep 08, 2016 $1.77 $1.89 $1.73 $1.83 237 200
Sep 07, 2016 $1.82 $1.90 $1.82 $1.82 143 200
Sep 06, 2016 $1.83 $1.90 $1.82 $1.82 182 600
Sep 02, 2016 $1.92 $1.92 $1.81 $1.84 80 100
Sep 01, 2016 $1.85 $1.86 $1.78 $1.86 118 100
Aug 31, 2016 $1.86 $1.86 $1.77 $1.81 230 100
Aug 30, 2016 $2.05 $2.10 $1.74 $1.88 1 044 200
Aug 29, 2016 $1.93 $2.35 $1.93 $2.00 4 126 400
Aug 26, 2016 $1.90 $1.94 $1.90 $1.90 18 000
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT